Lisa Prosser
Professor
Email:
[email protected]
Available to mentor
Lisa Prosser
Professor
Manage Your Profile
Center Memberships
-
Center MemberOpioid Research Institute
-
Center MemberCaswell Diabetes Institute
-
Center MemberInstitute for Healthcare Policy and Innovation
Recent Publications
-
Mckenna A, Rind DM, Mcqueen RB, Zemplenyi A, Prosser LA, Richardson M, Cassim S, Phillips M, Gyamfi HG, Ollendorf DA. Journal of Managed Care and Specialty Pharmacy, 2026 Oct 1; 32 (10): 1313 - 1318.Journal ArticleVaccines for COVID-19: Effectiveness and value: A summary from the Institute for Clinical and Economic Review’s New England Comparative Effectiveness Public Advisory Council
DOI:10.18553/jmcp.2026.32.10.1313 PMID: 42808544 -
Smith HS, Stein S, Henry MW, Lam WKK, Ream MA, Ojodu J, Jones E, Comeau AM, Tanksley S, Prosser LA, Kemper AR, Grosse SD. Pediatrics, 2026 Sep 1; 158: S38 - S50.Journal ArticleDecision Analysis to Inform Screening of the Young: An Interactive Newborn Screening Model
DOI:10.1542/peds.2026-077357G PMID: 42674594 -
Johnson S, Nguyen H, Stockwell M, Porucznik C, Karron R, Dawood F, Prosser L, Sarakki A, Stanford J, Hetrich M, Schappell E, Knoll M, Veguilla V, Mellis A, Duque J, Jeddy Z, Pike J, Rolfes M. Journal of Health Economics and Outcomes Research, 2026 Jul 30; 16 - 26.Journal ArticleEstimating Impact of SARS-CoV-2 Infection on Health-Related Quality of Life Among Persons Aged 8 Years and Older, August 2020–July 2022
DOI:10.36469/jheor.2026.163131 -
Cadham C, Ali S, Meza R, Prosser L. Value in Health, 2026 Jun 28; 29 (6): s100Journal ArticleEE198 DEVELOPING DIRECT EQUITY WEIGHTS FOR COST-EFFECTIVENESS ANALYSIS: RESULTS FROM A US-BASED DISCRETE CHOICE EXPERIMENT
DOI:10.1016/j.jval.2026.03.493 -
Darwar R, Shah D, Rose A, Prosser L. Value in Health, 2026 Jun 28; 29 (6): s115Journal ArticleEE274 ASSESSING THE VALUE OF LOST SCHOOLING DUE TO ILLNESS AMONG CHILDREN IN THE UNITED STATES
DOI:10.1016/j.jval.2026.03.568 -
Prosser LA, Hutton DW. JAMA Pediatr, 2026 Apr 13;Journal ArticleWhen Cost-Effectiveness Crosses Borders-Nirsevimab as an Example.
DOI:10.1001/jamapediatrics.2026.0823 PMID: 41973441 -
Matza LS, Rowen D, Chandler F, Dalziel K, Ghabri S, Law EH, Prosser LA, Rivero-Arias O, Shah K, Stolk E, Wolff J, Devlin N. Value in Health, 2026 Apr 1; 29 (4): 535 - 546.Journal ArticleValuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force
DOI:10.1016/j.jval.2025.12.016 PMID: 41581858 -
Chiang WL, Jong YJ, Prosser LA, Chen HF, Chen CY, Hsieh HM. Value in Health Regional Issues, 2026 Jan 1;Journal ArticleCost-Effectiveness of Universal Newborn Screening and Disease-Modifying Therapies for Spinal Muscular Atrophy in Taiwan
DOI:10.1016/j.vhri.2026.101654
Featured News & Stories
Health Lab
Broad COVID-19 vaccination makes economic sense, especially for older adults
COVID-19 vaccination of people over 65 would save the country money, and vaccination of younger groups of adults would be a reasonable investment
Health Lab
Investing in COVID-19 vaccination more than paid off for U.S.
The money spent to develop, test, buy and administer the first COVID-19 vaccine was more than made up for by prevented medical care and lost productivity.
